Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma.
Liu C, Ding X, Li G, Zhang Y, Shao Y, Liu L, Zhang W, Ma Y, Guan W, Wang L, Xu Z, Chang Y, Zhang Y, Jiang B, Yin Q, Tao R.
Liu C, et al. Among authors: jiang b.
iScience. 2023 Jul 13;26(8):107369. doi: 10.1016/j.isci.2023.107369. eCollection 2023 Aug 18.
iScience. 2023.
PMID: 37539026
Free PMC article.